This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
Fears over artificial intelligence disruption have sparked volatility across multiple industries that investors worry could be fully upended by new technology. In addition, the war in Iran has added ...
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...
Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 70,000 newsletter subscribers for 21 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results